Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Condition(s):Immunosuppresion; Thrombocytopenia; Pancytopenia; NeutropeniaLast Updated:June 8, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Immunosuppresion; Thrombocytopenia; Pancytopenia; NeutropeniaLast Updated:June 8, 2017Completed
Condition(s):Aplastic Anemia; CSA; Drug TherapyLast Updated:August 24, 2023Recruiting
Condition(s):Severe Aplastic Anemia; MDS (Myelodysplastic Syndrome)Last Updated:March 22, 2024Recruiting
Condition(s):CytopaeniaLast Updated:May 3, 2019Completed
Condition(s):Aplastic Anemia; Hypoplastic Myelodysplastic SyndromeLast Updated:December 29, 2020Completed
Condition(s):Myeloid DiseasesLast Updated:November 30, 2023Active, not recruiting
Condition(s):Acquired Aplastic Anemia.Last Updated:April 1, 2016Unknown status
Condition(s):Aplastic Anemia; Drug EffectLast Updated:January 28, 2021Unknown status
Condition(s):Aplastic Anemia; Myelodysplastic Syndromes; Fungal InfectionLast Updated:April 24, 2018Unknown status
Condition(s):Graft Versus Host Disease; Aplastic AnemiaLast Updated:June 24, 2005Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.